The future of clinical trials is digital—and AI is at the forefront of this transformation. In this episode, Medable Co-founder and CEO Michelle Longmire joins the Emerj podcast to discuss how AI is reshaping the clinical trial experience for patients, sites, and sponsors. From streamlining trial design to optimizing evidence generation, Michelle shares insights on leveraging AI for faster, more efficient drug development. She also dives into the importance of a portfolio-level digital strategy and how organizations can successfully navigate the change management required to embrace AI innovation in clinical research.